Split History
ETFs Holding BIOC »    BIOC Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Biocept is an early stage molecular oncology diagnostics company. Co. is engaged in the development and commercialization of proprietary circulating tumor cell (CTC), and circulating tumor DNA (ctDNA), assays utilizing a standard blood sample (liquid biopsy). Co.'s existing assays focuses on key solid tumor indications utilizing its Target-Selector™ liquid biopsy offering for the biomarker analysis of CTCs and ctDNA from a standard blood sample. Co. has commercialized its Target-Selector assays for a number of solid tumor indications such as: breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, and melanoma. According to our BIOC split history records, Biocept has had 1 split.
BIOC split history picture
Biocept (BIOC) has 1 split in our BIOC split history database. The split for BIOC took place on September 29, 2016. This was a 1 for 3 reverse split, meaning for each 3 shares of BIOC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 333.333333333333 share position following the split.

When a company such as Biocept conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the BIOC split history from start to finish, an original position size of 1000 shares would have turned into 333.333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Biocept shares, starting with a $10,000 purchase of BIOC, presented on a split-history-adjusted basis factoring in the complete BIOC split history. BIOC split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/22/2008
End date: 05/21/2018
Start price/share: $21.87
End price/share: $0.18
Dividends collected/share: $0.00
Total return: -99.18%
Average Annual Total Return: -38.11%
Starting investment: $10,000.00
Ending investment: $82.34
Years: 10.00
Date Ratio
09/29/20161 for 3
BIOC is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

BIOD Split History
BIOL Split History
BMRA Split History
BMY Split History
BONE Split History
BOTA Split History
BPAX Split History
BPTH Split History
BRLI Split History
BSPM Split History

Exponent, Inc. (EXPO)
Jewett-Cameron Trading Company Ltd. (JCTCF)
ProShares UltraShort Basic Materials (SMN)
ProShares Short Financials (SEF)
ProShares UltraPro Short Nasdaq Biotechnology (ZBIO)
ProShares UltraShort Semiconductors (SSG)
ProShares UltraShort FTSE China 50 (FXP)
ProShares Short Dow30 (DOG)
ProShares UltraShort QQQ (QID)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BIOC Insider Buying

BIOC Split History | www.SplitHistory.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.